Tandem Diabetes Care (TNDM) Misses Q3 EPS by 3c

Tandem Diabetes Care (NASDAQ: TNDM) reported Q3 EPS of ($0.85), $0.03 worse than the analyst estimate of ($0.82). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.6 million.

For earnings history and earnings-related data on Tandem Diabetes Care (TNDM) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Baird Upgrades Titan Machinery (TITN) to Outperform
• Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak